Literature DB >> 23218898

Schema therapy for bipolar disorder: a conceptual model and future directions.

Lisa D Hawke1, Martin D Provencher, Sagar V Parikh.   

Abstract

Schema therapy (ST) is an integrative form of psychotherapy developed for complex, chronic psychological disorders with a characterlogical underpinning. Bipolar disorder is just such a disorder--complex and often comorbid, with demonstrated stable cognitive and personality features that complicate the course of illness. This article presents the reasons justifying the application of ST to bipolar disorder and proposes a treatment rationale and future directions for treatment and research. If well adapted to the characteristics of bipolar disorder, ST might prove to be an effective adjunctive psychotherapy option that attenuates emotional reactivity, reduces symptoms and improves quality of life.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23218898     DOI: 10.1016/j.jad.2012.10.034

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Effects of the Schema Therapy and Mindfulness on the Maladaptive Schemas Hold by the Psoriasis Patients with the Psychopathology Symptoms.

Authors:  Parvin Jamali Gojani; Mohsen Masjedi; Shahnaz Khaleghipour; Ehsan Behzadi
Journal:  Adv Biomed Res       Date:  2017-01-31

2.  Psychometric validation of the Young Parenting Inventory - Revised (YPI-R2): Replication and Extension of a commonly used parenting scale in Schema Therapy (ST) research and practice.

Authors:  John Philip Louis; Alex M Wood; George Lockwood
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 3.  Schema Therapy for Patients with Bipolar Disorder: Theoretical Framework and Application.

Authors:  Marie Ociskova; Jan Prasko; Krystof Kantor; Frantisek Hodny; Pavel Kasyanik; Michaela Holubova; Jakub Vanek; Milos Slepecky; Vlastimil Nesnidal; Kamila Minarikova Belohradova
Journal:  Neuropsychiatr Dis Treat       Date:  2022-01-06       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.